The National Clinician Scholars Program (NCSP) is an interprofessional fellowship program designed to prepare a select group of future clinician leaders through scholarship and action at the national, state, and local levels. On July 1, the NCSP at Yale...
On June 25, Yale School of Medicine’s Dr. Jeanette Tetrault spoke at a convening of the President’s Opioid Commission and the Office of National Drug Control Policy. The purpose of the meeting was to discuss the steps needed to build a national addiction...
A tool developed by researchers at Yale, Stanford, and Bioethics International can promote greater sharing of clinical trial data by pharmaceutical companies. While nearly one-third of the companies that the researchers assessed met standards for sharing...
Treatments for Parkinson’s disease have most recently focused on increasing dopamine, a chemical messenger in the brain that affects reward-based behaviors and motivation, as well as movement. A new study by Yale researchers challenges long-held...
In a new study, Yale researchers challenge a long-held assumption about how insulin-producing cells in the pancreas sense and respond to glucose. Their findings could lead to changes in the way that scientists approach the treatment of diabetes, the...
Adults who take several prescription medications are more likely to experience serious falls, say Yale researchers and their co-authors in a new study. This heightened risk can affect middle-aged individuals — a population not typically viewed as...
When heart disease affects people under age 50, it’s considered “early onset” and experts believe there’s a genetic link. Yale investigators have found that a particular gene is common to families with multiple members who either have early-onset heart...